Publications by authors named "Dale R Shepard"

Claim this Profile
A
A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.
Scott M Schuetze, Karla V Ballman, Rachel Heise, Kristen N Ganjoo, Elizabeth J Davis, Dale R Shepard

Clin Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case report.
David S Buchberger, Samantha K Cook, Peter M Anderson, Dale R Shepard, Jamie A Ku

Pediatr Blood Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Time to Treatment Initiation Data in Musculoskeletal Soft Tissue Sarcoma.
Joshua M Lawrenz, Jose F Vega, Jaiben George, Gannon L Curtis, Jaymeson Gordon, Dale R Shepard

Sarcoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment.
Muhammad Wasif Saif, Carlos R Becerra, Marwan G Fakih, Weijing Sun, Lazar Popovic, Dale R Shepard

Cancer Chemother Pharmacol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral Injection of -NT Spores in Patients with Treatment-refractory Advanced Solid Tumors.
Filip Janku, Halle Huihong Zhang, Abdulmohammad Pezeshki, Sanjay Goel, Ravi Murthy, Dale R Shepard

Clin Cancer Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone Sarcoma.
Joshua M Lawrenz, Joseph Featherall, Gannon L Curtis, Jaiben George, Yuxuan Jin, Dale R Shepard

Sarcoma· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who Needs What? Perceptions of Patients and Caregivers in Oncology Phase 1 Trials.
Victoria Rezash, Janice Reed, Barbara Gedeon, Eric Parsons, Sandra Siedlecki, Dale R Shepard

J Patient Exp· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.
Lawrence Fong, Andrew Hotson, John D Powderly, Mario Sznol, Rebecca S Heist, Dale R Shepard

Cancer Discov· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors.
Ezra E W Cohen, Michael J Pishvaian, Dale R Shepard, Ding Wang, Jared Weiss

J Immunother Cancer· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors.
M Dror Michaelson, Shilpa Gupta, Neeraj Agarwal, Russell Szmulewitz, Thomas Powles, Dale R Shepard

Oncologist· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.
Muhammad Wasif Saif, Lee Rosen, Michelle A Rudek, Weijing Sun, Dale R Shepard

Br J Clin Pharmacol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer Database.
Joshua M Lawrenz, Gannon L Curtis, Joseph F Styron, Jaiben George, Peter M Anderson, Dale R Shepard

Sarcoma· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study to assess the mass balance, excretion, and pharmacokinetics of [C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors.
Neeraj Gupta, Steven Zhang, Sandeepraj Pusalkar, Mihaela Plesescu, Swapan Chowdhury, Dale R Shepard

Invest New Drugs· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database.
Gannon L Curtis, Joshua M Lawrenz, Jaiben George, Joe F Styron, Jacob Scott, Dale R Shepard

J Surg Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.
Ding Wang, Fadi Braiteh, James J Lee, Crystal S Denlinger, Dale R Shepard

Cancer Chemother Pharmacol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors.
David C Smith, John Powderly, James J Lee, Dale R Shepard, Johan Wallin

Cancer Chemother Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.
Laura Q M Chow, David C Smith, Antoinette R Tan, Crystal S Denlinger, Ding Wang, Dale R Shepard

Cancer Chemother Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma.
Dale R Shepard, Matthew M Cooney, Paul Elson, Ronald M Bukowski, Robert Dreicer

Invest New Drugs· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zibotentan for the treatment of castrate-resistant prostate cancer.
Dale R Shepard, Robert Dreicer

Expert Opin Investig Drugs· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.
David M Peereboom, Dale R Shepard, Manmeet S Ahluwalia, Cathy J Brewer, Neeraj Agarwal

J Neurooncol· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial comment.
Dale R Shepard

Urology· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations in the systemic therapy of prostate cancer.
Dale R Shepard, Derek Raghavan

Nat Rev Clin Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity associated with the long-term use of targeted therapies in patients with advanced renal cell carcinoma.
Dale R Shepard, Jorge A Garcia

Expert Rev Anticancer Ther· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender, hyperlipidemia, and coronary artery disease.
Dale R Shepard, Hani Jneid, Holly L Thacker

Compr Ther· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracil.
Dale R Shepard, Sridhar Mani, Helen Kastrissios, Susan Learned-Coughlin, Deborah Smith

Cancer Chemother Pharmacol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis